Quantexa Recognized as a Technology Standout in Celent’s 2023 xCelent AML Transaction Monitoring Report

Quantexa’s Decision Intelligence Platform and Financial Crime solutions credited for driving efficiencies through automation and enriching graph analytics and network analysis LONDON and NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) — Today Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced that it has been recognized by Celent, […]

Read More »

WillScot Mobile Mini to Announce Second Quarter 2023 Results on August 2, 2023

PHOENIX, July 19, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC) today announced it will release its second quarter 2023 financial results on Wednesday, August 2, 2023, after market close. Chief Executive Officer Brad Soultz and President and Chief Financial Officer Tim Boswell will host a […]

Read More »

VCI Global Collaborates With Treasure Global Inc To Develop AI-Powered Travel Platform To Tap On USD1 Trillion Digital Economy

KUALA LUMPUR, Malaysia, July 19, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) announced that the Company will be collaborating with Treasure Global Inc (NASDAQ: TGL) (“TGL” or “Treasure Global”) to develop an artificial intelligence (“AI”)-powered travel platform to heighten the travelling experiences for travellers in Malaysia. This AI-powered […]

Read More »

Synchronoss and Verizon Sign Cloud Contract Extension through 2030

Building on a 10-Year Partnership, Verizon will Continue to Utilize Synchronoss Personal Cloud to Enable Subscribers to Manage, Optimize, and Share All Types of Digital Content BRIDGEWATER, N.J., July 19, 2023 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and digital products and […]

Read More »

GenEmbryomics Engages WallachBeth to Pursue Listing on a US National Stock Exchange

MELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) — GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has retained WallachBeth Capital (“WallachBeth”) as its financial advisor and investment banker to provide general financial advisory and investment banking services to the Company as it pursues a listing on a US national […]

Read More »